Indo Count Industries is an Indian home textile exporter that has built a two-part model: a core bed linen business made in India and sold largely to US retailers, and a newer US-based utility bedding and branded soft-home business. The core business, which contributed about ₹837 crore in Q1 FY27 on 23 million meters, is a high-volume exporter to the US, with roughly 70% of core revenue from that market. The new business—pillows, mattress protectors, and brands such as Wamsutta and Tommy Hilfiger—contributed ₹387 crore in the same quarter and is entirely US-sourced and US-sold. The industry is fragmented, but Indo Count has held its share despite tariff shocks and claims a Gold Trophy for highest bed-sheet exports for six consecutive years. Its blended EBITDA margin was 13.1% in Q1 FY27, up 241 bps sequentially, but management targets 15-16% as new businesses reach scale, a level that indicates a good, not exceptional, structural margin.
The persistence of these economics rests on customer switching costs and the time to replicate its US manufacturing footprint. Large US retailers have multi-year sourcing relationships; even at a 50% US tariff, Indo Count lost no orders or customers. The company has more than doubled US pillow capacity to 31 million units across three facilities, with a greenfield North Carolina plant commissioned in January 2026. That asset base, plus licensed brand portfolio (Tommy Hilfiger, Wamsutta, Beautyrest, among others), creates an integrated supply chain from Indian fabric to US-made pillows and branded soft home lines. The core bed linen remains a commodity-like segment with pricing power limited to pass-through cost increases, but the new business shifts the mix toward higher-margin, intellectual-property-backed products. The barrier is not technology but the accumulated trust, brand licenses, and geography that take years for a competitor to match.
The inflection is already underway. The North Carolina facility is operational but only at 60-65% utilization, and management expects the utility bedding segment to reach similar utilization across all US plants in FY27. For FY27, the company guides to consolidated revenue of ₹5,500 crore, a 13% EBITDA margin, and core volumes of 105-110 million meters versus 94 million in FY26. New business revenue is guided at ₹1,500 crore for FY27, up from ₹792 crore in FY26. Eighteen to twenty-four months from now, that trajectory points to a business generating roughly ₹8,000 crore in revenue on a calendar-year 2028 basis, with new business contributing about USD 275 million (approximately ₹2,300 crore) and core business growing on the back of India-EU and UK free-trade agreements that eliminate duties. Margins should be around 15-16% as the utility bedding business reaches its targeted 15% EBITDA and the brand business delivers 100-200 bps better, eliminating the 150-200 bps incubation drag that persists into Q4 FY26.
Management's walk has been mixed, but the most recent quarter shows the direction is correct. In the November 2025 call, management promised the North Carolina facility would be operational by January 2026; it was commissioned on schedule. They also promised the 150-200 bps margin hit from US investments would be eliminated by Q4 FY26—that has not fully happened, but Q1 FY27 EBITDA margin improved to 13.1% from 10.7% in the prior quarter. They have maintained the USD 275 million new-business revenue target for 2028 and the FY27 volume guidance of 105-110 million meters. However, they repeatedly pushed out EBITDA margin guidance: originally aiming for 16-18%, they now guide to ~13% for FY27, acknowledging a gradual crawl back to 15-16%. Capital allocation remains disciplined: INR 250 crore capex over 12-18 months, 75% funded internally, with net debt-to-equity at 0.34x and interest cost run-rate of ~₹120 crore per year.
The quantified earnings path is straightforward: if FY27 revenue of ₹5,500 crore and a 13% EBITDA margin holds, that implies ~₹715 crore EBITDA. Scaling to ₹8,000 crore at 15% by CY2028 would yield ~₹1,200 crore EBITDA, roughly 70% higher. The critical lever is utilization—utility bedding must move from 60-65% toward optimal levels, and the brand business must sustain its early momentum (Q1 FY27 brand revenue was just above ₹125 crore, aligning with a ~₹500 crore FY27 target). The most important falsifier is US facility utilization: if it remains stuck below 70% by mid-2028, the margin expansion to 15-16% will not materialize, and the revenue target will be met only with lower profitability. Other near-term risks include container availability from West Asia conflict and the Bhilad plant flooding that partially curtailed production in July-August 2026, though management expects to make up lost ground. The tension between earlier delayed guidance and recent sequential margin improvement resolves to an operational rather than structural issue: the core business is competitive, but new-business gestation costs are compressing margin until volumes absorb the fixed base.
companyname: Indo Count Industries Limited ticker: ICIL sector: Textiles / Home Textiles Indo Count Industries Limited is a global home textile manufacturer headquartered in Mumbai, incorporated in 1988. The company started as a spinning enterprise in Kolhapur, Maharashtra, pivoted into home textiles in 2005, and now operates vertically integrated manufacturing - from cotton to finished product - across India and the United States. The business is formally split into two verticals: core busine...
Read the full report →capex, margin expansion, regulatory approval, new product segment
Revenue to double by FY28; USD 275 million from new businesses (utility bedding USD 175 million + brands USD 100 million)
Guidance maintainedmixed
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Indo Count Industries Limited and 4,900+ companies.
5-day free pass. No card required.